Erlewein, Katrin
Gossmann, Emily
Fegert, Jörg M.
Funding for this research was provided by:
Ministry of Science, Research and the Arts of Baden-Württemberg
Article History
Received: 26 January 2024
Accepted: 13 March 2024
First Online: 29 March 2024
Declarations
:
: Not applicable.
: All authors have read and agreed to the published version of the manuscript.
: The authors EG and KE declare no competing interests. In the last five years, JMF received research funding from EU, BMG (Federal Ministry of Health), BMBF (Federal Ministry of Education and Research), BMFSFJ (Federal Ministry of Family, Senior Citizens, Women and Youth), DFG (German Research Foundation), G-BA Innovation Fund, State Ministries Baden-Württemberg and Saarland, State Foundation Baden-Württemberg, Ingrid & Frank Foundation, Foundation Deutsche Krebshilfe (German Cancer Charity), Auxilium Foundation, Vector Foundation, Evangelical-Lutheran Church in Württemberg, Porticus Foundation; Travel grants, honoraria, sponsorship for conferences and medical educational purposes from APK, Adenauer- und Ebert Foundation, Deutschlandfunk, DFG, DJI, DKSB, Infectopharm, med update, UNICEF, professional associations, universities and federal and state ministries; was a consultant for APK e.V., University Hospital Saarland/State Chancellery, federal and state ministries, Servier. No industry-sponsored lecture series, no shareholdings, no participation in pharmaceutical companies.
: A more detailed version of this commentary may appear in another journal at a later date.